MIRA Pharmaceuticals, Inc. (MIRA)
MIRA Stock Price Chart
Explore MIRA Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze MIRA price movements and trends.
MIRA Company Profile
Discover essential business fundamentals and corporate details for MIRA Pharmaceuticals, Inc. (MIRA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
14 Aug 2023
Employees
2.00
Website
https://mirapharmaceuticals.comCEO
Erez Aminov
Description
MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog. This compound is undergoing investigation for its potential to address anxiety and the cognitive impairments frequently observed in adult patients suffering from early-stage dementia. The firm's lead candidate, MIRA1a, is a synthetic cannabinoid analog engineered to alleviate both anxiety and chronic pain through its interaction with cannabinoid type 1 and type 2 receptors. Originally established in 2020 as MIRA1a Therapeutics, Inc., MIRA Pharmaceuticals, Inc. maintains its headquarters in Baltimore, Maryland.
MIRA Financial Timeline
Browse a chronological timeline of MIRA Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Sept 2026
Earnings released on 14 May 2026
EPS came in at -$0.03 .
Earnings released on 31 Mar 2026
EPS came in at -$0.15 falling short of the estimated -$0.04 by -275.00%.
Earnings released on 13 Nov 2025
EPS came in at -$1.18 matching the estimated -$1.18.
Earnings released on 14 Aug 2025
EPS came in at -$0.09 surpassing the estimated -$0.11 by +18.18%.
Earnings released on 14 May 2025
EPS came in at -$0.11 surpassing the estimated -$0.15 by +26.67%.
Earnings released on 28 Mar 2025
EPS came in at -$0.15 surpassing the estimated -$0.29 by +48.28%, while revenue for the quarter reached $11.16m .
Earnings released on 12 Nov 2024
EPS came in at -$0.14 surpassing the estimated -$0.18 by +22.22%.
Earnings released on 13 Aug 2024
EPS came in at -$0.11 falling short of the estimated -$0.10 by -10.00%.
Earnings released on 13 May 2024
EPS came in at -$0.12 falling short of the estimated -$0.10 by -20.00%.
Earnings released on 1 Apr 2024
EPS came in at -$0.39 falling short of the estimated -$0.23 by -70.23%.
Earnings released on 13 Nov 2023
EPS came in at -$0.26 falling short of the estimated -$0.08 by -225.00%.
Earnings released on 15 Sept 2023
EPS came in at -$0.10 .
Earnings released on 31 Mar 2023
EPS came in at -$0.09 .
Earnings released on 31 Dec 2022
EPS came in at -$43.86 .
Earnings released on 30 Sept 2022
EPS came in at -$0.12 .
Earnings released on 30 Jun 2022
EPS came in at -$0.16 .
Earnings released on 31 Mar 2022
EPS came in at -$0.10 .
MIRA Stock Performance
Access detailed MIRA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
